Terms: = Cervical cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Treatment
157 results:
1. METTL3's role in cervical cancer development through m
Liu Y; Li C; Deng Q; Ren X; Wang H
FASEB J; 2024 Jun; 38(11):e23693. PubMed ID: 38809685
[TBL] [Abstract] [Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mtor pathway and tubulin inhibition.
Li SS; Chen JJ; Zhang MM; Wang WX; Zhang WY; Ma C
Eur J Med Chem; 2024 May; 271():116425. PubMed ID: 38636129
[TBL] [Abstract] [Full Text] [Related]
3. Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mtor pathway.
Yin Q; Zhou Q; Hu J; Weng J; Liu S; Yin L; Long L; Tong Y; Tang K; Bai S; Ou L
J Trace Elem Med Biol; 2024 Jul; 84():127437. PubMed ID: 38564977
[TBL] [Abstract] [Full Text] [Related]
4. Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
Khan NG; Adiga D; Rai PS; Kabekkodu SP
Toxicology; 2024 May; 504():153791. PubMed ID: 38555994
[TBL] [Abstract] [Full Text] [Related]
5. Comparative analysis of chemical profiles, antioxidant, antibacterial, and anticancer effects of essential oils of two Thymus species from Montenegro.
Preljević K; Pašić I; Vlaović M; Matić IZ; Krivokapić S; Petrović N; Stanojković T; Živković V; Perović S
Fitoterapia; 2024 Apr; 174():105871. PubMed ID: 38428618
[TBL] [Abstract] [Full Text] [Related]
6. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
7. Genetics and beyond: Precision Medicine Real-World Data for Patients with cervical, Vaginal or Vulvar cancer in a Tertiary cancer Center.
Kraus FBT; Sultova E; Heinrich K; Jung A; Westphalen CB; Tauber CV; Kumbrink J; Rudelius M; Klauschen F; Greif PA; König A; Chelariu-Raicu A; Czogalla B; Burges A; Mahner S; Wuerstlein R; Trillsch F
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397025
[TBL] [Abstract] [Full Text] [Related]
8. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
[TBL] [Abstract] [Full Text] [Related]
9. Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
Wang J; Mou X; Lu H; Jiang H; Xian Y; Wei X; Huang Z; Tang S; Cen H; Dong M; Liang Y; Shi G
Front Endocrinol (Lausanne); 2023; 14():1302074. PubMed ID: 38327905
[TBL] [Abstract] [Full Text] [Related]
10. Acetylmelodorinol isolated from Sphaerocoryne affinis seeds inhibits cell proliferation and activates apoptosis on HeLa cells.
Le-Trung N; Kanaori K; Waku T; Dang TTP; Kamei K
BMC Complement Med Ther; 2024 Jan; 24(1):59. PubMed ID: 38281034
[TBL] [Abstract] [Full Text] [Related]
11. Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer.
Zhou J; Li H; Wu B; Zhu L; Huang Q; Guo Z; He Q; Wang L; Peng X; Guo T
Sci Rep; 2024 Jan; 14(1):1860. PubMed ID: 38253629
[TBL] [Abstract] [Full Text] [Related]
12. Phase I Study of mtorC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mtor/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
13. The effects of HPV oncoproteins on host communication networks: Therapeutic connotations.
Skelin J; Luk HY; Butorac D; Boon SS; Tomaić V
J Med Virol; 2023 Dec; 95(12):e29315. PubMed ID: 38115222
[TBL] [Abstract] [Full Text] [Related]
14. Maackiain suppresses the development of cervical cancer via AMPK priming autophagy.
He J; Xiang L; Zhu T; Wang H; Huang Y; Li H; Miao C; Zhuang Y; Cao Y
J Pharm Pharmacol; 2024 Jan; 76(1):23-33. PubMed ID: 37934902
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
16. Silibinin Downregulates Types I and III Collagen Expression via Suppression of the mtor Signaling Pathway.
Choi S; Ham S; Lee YI; Kim J; Lee WJ; Lee JH
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762688
[TBL] [Abstract] [Full Text] [Related]
17. Potent anti-cancer activity of Sphaerocoryne affinis fruit against cervical cancer HeLa cells via inhibition of cell proliferation and induction of apoptosis.
Le-Trung N; Duong TM; Dang TTP; Kamei K
BMC Complement Med Ther; 2023 Aug; 23(1):290. PubMed ID: 37598145
[TBL] [Abstract] [Full Text] [Related]
18. FNBP1 Facilitates cervical cancer Cell Survival by the Constitutive Activation of FAK/PI3K/AKT/mtor Signaling.
Zhang J; Li X; Zhou Y; Lin M; Zhang Q; Wang Y
Cells; 2023 Jul; 12(15):. PubMed ID: 37566043
[TBL] [Abstract] [Full Text] [Related]
19. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
20. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
[Next]